Search alternatives:
significant event » significant effect (Expand Search), significant level (Expand Search), significant effects (Expand Search)
event regions » seven regions (Expand Search), desert regions (Expand Search), select regions (Expand Search)
gap decrease » gain decreased (Expand Search), mean decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant event » significant effect (Expand Search), significant level (Expand Search), significant effects (Expand Search)
event regions » seven regions (Expand Search), desert regions (Expand Search), select regions (Expand Search)
gap decrease » gain decreased (Expand Search), mean decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
61
-
62
-
63
-
64
-
65
Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx
Published 2023“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
-
66
Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx
Published 2023“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
-
67
Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx
Published 2023“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
-
68
Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx
Published 2023“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040.
Published 2025Subjects: -
77
-
78
-
79
-
80